<VariationArchive VariationID="429506" VariationName="NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs)" VariationType="Deletion" Accession="VCV000429506" Version="15" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-19" DateCreated="2017-07-02" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="421700" VariationID="429506">
      <GeneList>
        <Gene Symbol="ENG" FullName="endoglin" GeneID="2022" HGNC_ID="HGNC:3349" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127815016" stop="127854658" display_start="127815016" display_stop="127854658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130577290" stop="130617046" display_start="130577290" display_stop="130617046" Strand="-" />
          </Location>
          <OMIM>131195</OMIM>
          <Haploinsufficiency last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="LOC102723566" FullName="uncharacterized LOC102723566" GeneID="102723566" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127816066" stop="127822520" display_start="127816066" display_stop="127822520" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs)</Name>
      <CanonicalSPDI>NC_000009.12:127819975:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127819976" stop="127819977" display_start="127819976" display_stop="127819977" variantLength="2" positionVCF="127819975" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130582255" stop="130582256" display_start="130582255" display_stop="130582256" variantLength="2" positionVCF="130582254" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R217fs</ProteinChange>
      <ProteinChange>R399fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.130582255_130582256del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.130582255_130582256del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.127819976_127819977del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.127819976_127819977del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009551.1" sequenceAccession="NG_009551" sequenceVersion="1" change="g.39792_39793del">
            <Expression>NG_009551.1:g.39792_39793del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.4" sequenceAccession="NM_000118" sequenceVersion="4" change="c.1195_1196delAG">
            <Expression>NM_000118.4:c.1195_1196delAG</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000109.1" sequenceAccession="NP_000109" sequenceVersion="1" change="p.Arg399Glyfs">
            <Expression>NP_000109.1:p.Arg399Glyfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.3" sequenceAccession="NM_001114753" sequenceVersion="3" change="c.1195_1196del" MANESelect="true">
            <Expression>NM_001114753.3:c.1195_1196del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108225.1" sequenceAccession="NP_001108225" sequenceVersion="1" change="p.Arg399fs">
            <Expression>NP_001108225.1:p.Arg399fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278138.2" sequenceAccession="NM_001278138" sequenceVersion="2" change="c.649_650del">
            <Expression>NM_001278138.2:c.649_650del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265067.1" sequenceAccession="NP_001265067" sequenceVersion="1" change="p.Arg217fs">
            <Expression>NP_001265067.1:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_589" sequenceAccession="LRG_589">
            <Expression>LRG_589:g.39792_39793del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t1" sequenceAccession="LRG_589t1">
            <Expression>LRG_589t1:c.1195_1196del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p1" sequenceAccession="LRG_589p1" change="p.Arg399fs">
            <Expression>LRG_589p1:p.Arg399fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t2" sequenceAccession="LRG_589t2">
            <Expression>LRG_589t2:c.1195_1196del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p2" sequenceAccession="LRG_589p2" change="p.Arg399Glyfs">
            <Expression>LRG_589p2:p.Arg399Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.3" sequenceAccession="NM_000118" sequenceVersion="3" change="c.1195_1196delAG">
            <Expression>NM_000118.3:c.1195_1196delAG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369413" DB="ClinGen" />
        <XRef Type="rs" ID="1131691422" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs) AND not provided" Accession="RCV000494067" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs) AND Telangiectasia, hereditary hemorrhagic, type 1" Accession="RCV001002195" Version="8">
        <ClassifiedConditionList TraitSetID="7437">
          <ClassifiedCondition DB="MedGen" ID="C4551861">Telangiectasia, hereditary hemorrhagic, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs) AND Hereditary hemorrhagic telangiectasia" Accession="RCV001385796" Version="5">
        <ClassifiedConditionList TraitSetID="43931">
          <ClassifiedCondition DB="MedGen" ID="C0039445">Hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1195_1196del (p.Arg399fs) AND ENG-related disorder" Accession="RCV003392321" Version="4">
        <ClassifiedConditionList TraitSetID="90248">
          <ClassifiedCondition>ENG-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-05" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-05" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2017-07-02" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15879500</ID>
        </Citation>
        <DescriptionHistory Dated="2020-02-09">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90248" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70305" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ENG-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENG-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENG-Related Disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="7437" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16695" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 1</ElementValue>
                <XRef ID="MONDO:0008535" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ORW1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HHT1</ElementValue>
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506220" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505110" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000227625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506222" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562015" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528884" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553700" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528531" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500544" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506221" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511259" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515716" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500545" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C4551861" DB="MedGen" />
              <XRef ID="MONDO:0008535" DB="MONDO" />
              <XRef Type="MIM" ID="187300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43931" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="40362" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Osler+hemorrhagic+telangiectasia+syndrome/9046" DB="Genetic Alliance" />
                <XRef ID="21877004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary hemorrhagic telangiectasia</ElementValue>
                <XRef ID="MONDO:0019180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ORW disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler-Rendu-Weber disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6626" />
                <XRef ID="6626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C0039445" DB="MedGen" />
              <XRef ID="MONDO:0019180" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS187300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1133851" SubmissionDate="2019-01-29" DateLastUpdated="2017-07-02" DateCreated="2017-07-02">
        <ClinVarSubmissionID localKey="GDX:1577517|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000582092" DateUpdated="2017-07-02" DateCreated="2017-07-02" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Although the c.1195_1196delAG likely pathogenic variant in the ENG gene has not been reported toour knowledge, this variant causes a shift in reading frame starting at codon arginine 399, changing itto a glycine, and creating a premature stop codon at position 2 of the new reading frame, denotedp.Arg399GlyfsX2. This likely pathogenic variant is expected to result in either an abnormal, truncatedprotein product or loss of protein from this allele through nonsense-mediated mRNA decay. Multipleother frameshift variants in the ENG gene have been reported in Human Gene Mutation Database inassociation with HHT (Stenson et al., 2014), indicating that loss of function is a mechanism of diseasefor this gene. Furthermore, the c.1195_1196delAG variant has not been observed in large populationcohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000118.2:c.1195_1196delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2284648" SubmissionDate="2019-08-05" DateLastUpdated="2020-02-10" DateCreated="2020-02-10">
        <ClinVarSubmissionID localKey="2205920|OMIM:187300" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001160068" DateUpdated="2020-02-10" DateCreated="2020-02-10" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ENG c.1195_1196delAG; p.Arg399fs variant, to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 429506). Our laboratory has previously detected this variant in another individual affected with HHT. Additionally, a similar deletion (c.1195delA; p.Arg399fs) is associated with HHT and considered to be pathogenic (see link). The c.1195_1196delAG variant is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant causes a frameshift by deleting two nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. REFERENCES HHT ENG database link: http://arup.utah.edu/database/ENG/ENG_display.php</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130582255_130582256delCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Aug 2019 ARUP</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7683938" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="36336619|ENG-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004112662" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The ENG c.1195_1196delAG variant is predicted to result in a frameshift and premature protein termination (p.Arg399Glyfs*2). To our knowledge, this variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ENG are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000118.3:c.1195_1196delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ENG-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111405" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11791819|MedGen:C0039445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585759" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15879500</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 429506). This variant has not been reported in the literature in individuals affected with ENG-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg399Glyfs*2) in the ENG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130582255_130582256del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1133851" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2284648" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7683938" TraitType="Disease" MappingType="Name" MappingValue="ENG-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ENG-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3111405" TraitType="Disease" MappingType="XRef" MappingValue="C0039445" MappingRef="MedGen">
        <MedGen CUI="C0039445" Name="Hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

